Welcome everyone to Episode 95 of The Stem Cell Podcast. As always go to stemcellpodcast.com for all of our episodes and to sign up or re-subscribe (if you are a current subscriber) for the newsletter.
The Science Round Up
For this week’s round-up, STEMCELL Technologies introduces Pulmonary Cell News. Covering everything lung, from COPD to CF to cancer, Pulmonary Cell News keeps readers current with the latest news, research, policy, events and jobs relevant to the lung research community. Check out Pulmonary Cell News and the rest of Connexon’s 20 science newsletters, all of which are provided by STEMCELL Technologies, at www.pulmonarycellnews.com
This week, in the world-famous Science Round Up, we discuss the latest science/stem cell news including:
- A new, see through frog.
- Mechanism for cause of Parkinson’s.
- A protein responsible for preeclampsia in moms.
- Clinical trials to begin with cells derived from Human ES Cells in China.
- Compound in grapes can kill colon cancer stem cells.
- Stem cell scientist to run for congress in California?
- Stem cells to understand chlamydia.
The interview with Dr. Darrell Kotton
In the interview portion of this episode, STEMCELL Technologies brings you the Flyer: PneumaCult-Ex Plus. This flyer provides an overview of the new and improved workflow to culture human primary airway epithelial cells at the air-liquid interface (ALI), using PneumaCult-Ex Plus for expansion and PneumaCult-ALI for differentiation.
- Increased Expansion: More population doublings at each passage
- Sustained ALI Differentiation Potential: Maintain morphological and electrophysiological characteristics even after extended passaging
- Stem cell podcast listeners can find get more technical resources at pneumacult.com
For the interview portion of the show, The Stem Cell Podcast and STEMCELL Technologies welcome Dr. Darrell Kotton to the show. Dr. Kotton is a David C. Seldin Professor of Medicine and works as the Director in the Center for Regenerative Medicine of Boston University and Boston Medical Center. Dr. Kotton’s research focuses on stem cell biology and gene therapy related to lung injury and repair. Dr. Kotton’s laboratory currently utilizes several stem cell populations, including bone marrow-derived stem cells and embryonic stem cells in order to develop novel stem cell-based therapies for lung disease. In addition, Dr. Kotton specializes in the genetic manipulation of stem cells as well as resident lung cells using lentiviral vectors.
After the interview, we close the show with a signature SCP rant.[Read more…]